Good evening, I'm Ravi Patel. We begin tonight with breaking developments in a rare but deadly outbreak aboard a cruise ship. Canadian health authorities have confirmed the first case of hantavirus linked to the MV Hondius outbreak, with the patient currently isolating in British Columbia. This comes as Dutch officials prepare to quarantine the ship’s remaining crew in Rotterdam, where 23 prefabricated cabins have been erected ahead of the vessel’s Monday arrival. The Andes hantavirus strain involved has already claimed three lives among the 11 confirmed cases, marking the first known shipboard outbreak of this virus, which can spread between humans. Health officials worldwide are on high alert, though they continue to emphasize that the risk to the general public remains low.

In medical research, scientists at the University of Pittsburgh School of Medicine have made a groundbreaking discovery in the fight against melanoma. Their study, published in Science, reveals how certain genetic mutations allow melanoma cells to evade the body’s natural aging limits, effectively making them "immortal." The findings could pave the way for new treatments targeting these mutations, offering hope for patients battling this aggressive form of skin cancer. Meanwhile, Regeneron Pharmaceuticals has shared promising Phase 3 trial results for a new melanoma treatment combining fianlimab and cemiplimab, showing improved outcomes for patients with unresectable or metastatic disease.

On another front, the FDA has approved an AI system developed by Johns Hopkins University that predicts sepsis up to 48 hours earlier than traditional methods. This tool, called the Targeted Real-Time Early Warning System, could significantly boost survival rates for a condition that kills over 350,000 Americans each year. And in a call to action, a WHO-appointed commission is urging the declaration of the climate crisis as a global public health emergency, warning of catastrophic consequences if immediate steps aren’t taken to address its far-reaching impacts.

Finally, a study from Stanford Medicine highlights a troubling trend: many patients are discontinuing statins, a widely prescribed cholesterol-lowering drug, due to negative perceptions spread online. Despite decades of evidence supporting their effectiveness, misinformation on platforms like Reddit appears to be influencing public trust in these lifesaving medications.

This is Ravi Patel, signing off. Stay informed, and join us again tomorrow for the latest updates.